Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Rank in Stocks #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Share Price
$0.0416118
Market Cap
$32.25M
Change (1 day)
-1.67%
Change (1 year)
-59.58%
Country
AU
Trade Neurizon Therapeutics Limited (NUZ)

Category

Stock price history for Neurizon Therapeutics Limited (NUZ)
Highest end of day price: $0.04 on 2026-08-01

Lowest end of day price: $3.11 on 2001-10-01
Stock price history of Neurizon Therapeutics Limited from 2001 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -8.62%
2025 -37.70%
2024 50.11%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH